← Browse by Condition
Medical Condition
lung transplant recipient
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for lung transplant recipient sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 2
Top Sponsors
2 trials
Recruiting Clinical Trials
NCT07189377 Phase 4
Recruiting
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Enrollment
20 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT07235683 Phase 4
Recruiting
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
Enrollment
40 pts
Location
Canada
Sponsor
University Health Network, Tor...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology